The chart is not accessible to screen readers. Please switch to the table view to access the data.
Advertisement
Advertisement
Share of adults with diagnosed diabetes who used GLP-1 injectables in the United States in 2024, by gender
Share of U.S. adults with diabetes using GLP-1 injectables in 2024, by gender
In 2024, 26.5 percent of adults in the United States with diagnosed diabetes reported using GLP-1 injectables. Women were slightly more likely to use these medications than men.
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
Other statistics that may interest you Statistics on
About the industry
10
- Basic Statistic Share of U.S. adults with diabetes using GLP-1 injectables 2024, by medication status
- Basic Statistic Share of U.S. adults with diabetes using GLP-1 injectables in 2024, by BMI
- Basic Statistic Share of U.S. adults with diabetes using GLP-1 injectables in 2024, by family income
- Premium Statistic Share of U.S. adults with diabetes using GLP-1 injectables in 2024, by race/ethnicity
- Basic Statistic Share of U.S. adults with diabetes using GLP-1 injectables in 2024, by age
- Basic Statistic Change in Canadian drug stores' top drug therapeutic class purchases 2024
- Basic Statistic Canadian drug stores' top drug therapeutic classes purchases 2024
- Premium Statistic Revenue per pharmacy in the pharmacies market in Suriname 2016-2030
- Premium Statistic Policy options Americans favor to keep the prescription drug costs down in 2021
- Premium Statistic Retail prescription drug expenditure distribution by payer in the U.S. 2005-2021
About the region
10
- Basic Statistic U.S. out-of-pocket per capita spending for insureds with diabetes by gender 2012-2014
- Premium Statistic Types of medical treatment among U.S. diabetes sufferers 2010-2012
- Basic Statistic Diabetes death rates for older U.S. adults 2000-2019, by gender
- Premium Statistic Annual U.S. per capita health expenditures for diabetes in 2017, by treatment type
- Basic Statistic New cases of diagnosed diabetes in the U.S. 2021, by gender
- Basic Statistic Rate of new cases of diagnosed diabetes in the U.S. 2019-2021, by gender
- Premium Statistic Adults with diabetes in the U.S. from 2017-2020, by gender and education
- Premium Statistic Lack of treatment of diabetes in the U.S. as of 2016
- Premium Statistic Use of GLP-1 for chronic conditions in the U.S. 2024-2025
- Premium Statistic Side effects due to GLP-1 intake in the U.S. 2025
Selected statistics
10
- Premium Statistic Pharmacy density in the UK 2021-2029
- Premium Statistic Online pharmacy user share in the UK 2020-2028
- Basic Statistic Average revenue per UK pharmacy 2021-2029
- Basic Statistic UK pharmacy market revenue 2021-2029
- Premium Statistic Sales revenue of medicaments via physical retail pharmacies in China 2011-2024
- Premium Statistic Sales revenue of medicaments via retail pharmacies in China 2011-2024
- Premium Statistic Sales revenue of medicaments via online retail pharmacies in China 2011-2024
- Premium Statistic Revenue of online pharmacies in Turkey 2017-2029
- Premium Statistic Number of pharmacies in Turkey 2016-2030
- Premium Statistic Revenue in the Antiviral Drugs segment in Poland 2016-2030
Other regions
10
- Premium Statistic Compensation of dispensed diabetes medicines and goods in the Netherlands 2014-2024
- Basic Statistic Dispensed diabetes medicines and goods in the Netherlands 2014-2024
- Basic Statistic Net sales of Novo Nordisk Q1 2021-Q4 2025
- Premium Statistic Diabetics count in Russia 2010-2022
- Premium Statistic Diabetes prevalence in Russia 2010-2022
- Premium Statistic Number of type 2 diabetic patients in Ghana 2019-2022, by age
- Premium Statistic Amount spent per capita on care by individuals with diabetes in Ghana 2019-2022
- Premium Statistic Amount spent on care by individuals with diabetes in Ghana 2019-2022, by age group
- Premium Statistic Total amount spent on care by individuals with diabetes in Ghana 2019-2022
- Premium Statistic Number of diabetics receiving health care in Italy 2018, by treatment
Related statistics
10
- Premium Statistic Number of insulin human/isophane combination prescriptions in the U.S. 2014-2023
- Basic Statistic Global next-generation biomanufacturing market size 2020 & 2031
- Premium Statistic Obstacles regarding health access for migrants in Libya 2021
- Basic Statistic Sufferers from chronic health conditions in South Africa 2019, by disease
- Premium Statistic Availability versus registrations for MBBS seats India 2015-2024
- Premium Statistic Share of healthcare sector profits to GDP 2003-2018
- Premium Statistic Number of medical colleges India FY 2016-2023
- Premium Statistic Global cancer medication prices in comparison to the U.S., 2018
- Basic Statistic Pharmaceutical excipients global market size 2023 vs forecast 2032
- Basic Statistic Supply chain priorities of U.S. provider and pharma/life sciences executives 2021
Further Content: You might find this interesting as well
* For commercial use only
Basic Account
For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
- Free Statistics
Based on your interests
Starter Account
For single users
$199 USD
per month, billed annually
1
- Free Statistics
- Premium Statistics
Professional Account
For teams of up to 99 users
Talk to sales for pricing
- Free + Premium Statistics
- Reports
- Market ÌÇÐÄÆƽâ°æ
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
NCHS, & CDC. (August 14, 2025). Share of adults with diagnosed diabetes who used GLP-1 injectables in the United States in 2024, by gender [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 22, 2026, from /statistics/1623532/us-adults-using-glp-1-injectables-by-gender/
NCHS, und CDC. "Share of adults with diagnosed diabetes who used GLP-1 injectables in the United States in 2024, by gender." Chart. August 14, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 22, 2026. /statistics/1623532/us-adults-using-glp-1-injectables-by-gender/
NCHS, CDC. (2025). Share of adults with diagnosed diabetes who used GLP-1 injectables in the United States in 2024, by gender. ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 22, 2026. /statistics/1623532/us-adults-using-glp-1-injectables-by-gender/
NCHS, and CDC. "Share of Adults with Diagnosed Diabetes Who Used Glp-1 Injectables in The United States in 2024, by Gender." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 14 Aug 2025, /statistics/1623532/us-adults-using-glp-1-injectables-by-gender/
NCHS & CDC, Share of adults with diagnosed diabetes who used GLP-1 injectables in the United States in 2024, by gender ÌÇÐÄÆƽâ°æ, /statistics/1623532/us-adults-using-glp-1-injectables-by-gender/ (last visited July 22, 2026)
Share of adults with diagnosed diabetes who used GLP-1 injectables in the United States in 2024, by gender [Graph], NCHS, & CDC, August 14, 2025. [Online]. Available: /statistics/1623532/us-adults-using-glp-1-injectables-by-gender/
Advertisement